Pharmaceutical
Rilonacept Regeneron: EPAR - Conditions imposed on member states for safe and effective use - Annex IV
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Advanced pharmaceutical formulation for targeted therapeutic intervention.